CA2015315A1 - Improved method of blood component decontamination by glucose addition and post-decontamination gassing - Google Patents

Improved method of blood component decontamination by glucose addition and post-decontamination gassing

Info

Publication number
CA2015315A1
CA2015315A1 CA002015315A CA2015315A CA2015315A1 CA 2015315 A1 CA2015315 A1 CA 2015315A1 CA 002015315 A CA002015315 A CA 002015315A CA 2015315 A CA2015315 A CA 2015315A CA 2015315 A1 CA2015315 A1 CA 2015315A1
Authority
CA
Canada
Prior art keywords
decontamination
gassing
post
improved method
blood component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002015315A
Other languages
French (fr)
Other versions
CA2015315C (en
Inventor
Gary P. Wiesehahn
Laurence Corash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Gary P. Wiesehahn
Laurence Corash
Diamond Scientific Co.
Miles Inc.
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/350,335 external-priority patent/US5176921A/en
Application filed by Gary P. Wiesehahn, Laurence Corash, Diamond Scientific Co., Miles Inc., Bayer Corporation filed Critical Gary P. Wiesehahn
Publication of CA2015315A1 publication Critical patent/CA2015315A1/en
Application granted granted Critical
Publication of CA2015315C publication Critical patent/CA2015315C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive.
CA 2015315 1989-05-11 1990-04-24 Improved method of blood component decontamination by glucose addition and post-decontamination gassing Expired - Lifetime CA2015315C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/350,335 1989-05-11
US07/350,335 US5176921A (en) 1983-05-02 1989-05-11 Method of blood component decontamination by glucose addition

Publications (2)

Publication Number Publication Date
CA2015315A1 true CA2015315A1 (en) 1990-11-11
CA2015315C CA2015315C (en) 2001-03-06

Family

ID=23376261

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2015315 Expired - Lifetime CA2015315C (en) 1989-05-11 1990-04-24 Improved method of blood component decontamination by glucose addition and post-decontamination gassing

Country Status (1)

Country Link
CA (1) CA2015315C (en)

Also Published As

Publication number Publication date
CA2015315C (en) 2001-03-06

Similar Documents

Publication Publication Date Title
AU563557B2 (en) Photochemical decontamination treatment of whole blood or blood components
BR8900529A (en) VASCULAR GRAFT AND PROCESS OF PREPARING AN ARTERY
ES8600613A1 (en) Body implants of extracellular matrix and means and methods of making and using such implants.
NO890089L (en) PROCEDURES FOR STIMULATING HAIR GROWTH.
AU7818487A (en) Intermittent aeration type biological treatment process and system therefor
AU6760987A (en) Method of treating alzheimer's disease
DE3689943D1 (en) Degraded tissue plasminogen activator species, pharmaceutical preparation, and method of making the same.
CA2169173A1 (en) Methods for stimulating erythropoiesis using thrombopoietin
HU902004D0 (en) New trombolitic preparations
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
Leach Mechanisms of endogenous N-nitrosation.
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
AU3861989A (en) Method for the treatment and the diagnosis of coronary heart disease
CA2015315A1 (en) Improved method of blood component decontamination by glucose addition and post-decontamination gassing
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
EP0200527A3 (en) Norfloxacin salt
FR2604361B1 (en) BALM FOR THE TREATMENT OF VARICUS AND BLOOD CIRCULATION DISEASES
SU645647A1 (en) Method of lobe-wise cutout of liver from blood circulation
DE68902569D1 (en) METHODS AND PREPARATIONS FOR THE TREATMENT OF NIDDM.
IL90867A0 (en) Method of non-invasive determination of glucose in the blood
Sergacheva et al. The effect of antihelminthic drugs, diphesyl and bemosate, on cholinesterase activity of whipworms and mice in experiments in vivo.
IL109759A0 (en) Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
IL82994A0 (en) Method of non-invasive determination of glucose in the blood

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry